comprehensive -WSS

comprehensive

author：comprehensive 2025-08-04 05:22:34 - browse：875

Has PhRMA lost its fangs? Are 11th-hour changes ominous for clinical trials? And what’s next in pain medicine?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. The pharmaceutical industry, in court and in Congress, is working to water down legislation that will let Medicare negotiate certain drug prices. STAT Washington correspondent Rachel Cohrs joins us to explain the industry’s struggle to make headway — and how it factors into the 2024 election. We also discuss the latest news in the life sciences, including a twist in the future of Alnylam Pharmaceuticals, competition to Vertex Pharmaceuticals’ pain drug, and Gilead Sciences’ latest acquisition.

For more on what we cover, here’s all of Rachel’s coverage; here’s more on Vertex’s competition; here’s the news on Gilead; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Heart attack and stroke risk calculators need revising
Next article： Maisha Meds is a PBM, but don't call it that

Wikipedia

WSS

A virus, fished out of a lake, may have saved a man’s life

Why Charlie Gard's case is so disturbing to Americans

VC firm General Catalyst wants to buy a health system

Pumping milk in bathrooms at health conferences is common

Liquid biopsy for lung cancer is launched by Delfi

Medicare drug price lawsuits could be good politics for Biden

leisure time

comprehensive

Wikipedia

Alkermes shareholders re

Physician executives need more than on

Medical records are filled with copy

FDA authorizes Novavax’s updated Covid

BioMarin wins approval for gene therapy to treat hemophilia A

Future doctors need a strong humanities education

Novavax promises a turnaround & Lilly roils the obesity market

Bristol 'take

DIEP, the 'gold standard' of breast reconstruction, is under threat

FDA authorizes Novavax’s updated Covid

entertainment

Dog Aging Project founders on what lies ahead after losing funding

Senate panel eyes new effort on drug shortages

Cardiologists urge adding sexual orientation, gender identity to health records

Immunocompromised patients offer clues on chronic Covid

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Pumping milk in bathrooms at health conferences is common

entertainment

hotspot

hotspot

focus